|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.84 - 0.90|
|52 Week Range||0.70 - 1.53|
|PE Ratio (TTM)||13.97|
|Earnings Date||Jan 10, 2017 - Jan 16, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||1.18|
Categories: Yahoo FinanceNeptune Technologies & Bioresources, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 72. Our analysis is based on comparing Neptune Technologies & Bioresources, Inc. with the following peers – Novelion Therapeutics Inc., Cipher Pharmaceuticals Inc., EcoSynthetix Inc. and TerraVia Holdings, Inc. (NVLN-US, CPH-CA, ECSNF-US and TVIAQ-US). Neptune Technologies & Bioresources, ... Read more (Read more...)
Neptune Technologies & Bioressources Inc. announces that the nominees listed in its management proxy circular dated July 13, 2017 were elected as directors of the Corporation. The detailed results of the ...
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of CaPre for the treatment of severe hypertriglyceridemia, announced that the following individuals ...